CD147 contributes to SARS-CoV-2-induced pulmonary fibrosis

Jiao Wu(Baylor College of Medicine), Zhi‐Nan Chen(Air Force Medical University)
Signal Transduction and Targeted Therapy
November 25, 2022
10.1038/s41392-022-01230-5
Cited by 62

Related Papers

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
|Signal Transduction and Targeted Therapy|2020|1.2k
TNF antagonist sensitizes synovial fibroblasts to ferroptotic cell death in collagen-induced arthritis mouse models
|Nature Communications|2022|256
RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression
|Theranostics|2019|88
Receptor‐Interacting Protein Kinase 3 Deficiency Recruits Myeloid‐Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C‐X‐C Motif) Ligand 1–Chemokine (C‐X‐C Motif) Receptor 2 Axis
|Hepatology|2019|74
A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells
|Oncotarget|2016|65